Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4161391
Max Phase: Preclinical
Molecular Formula: C59H98N12O13
Molecular Weight: 1183.50
Molecule Type: Small molecule
Associated Items:
ID: ALA4161391
Max Phase: Preclinical
Molecular Formula: C59H98N12O13
Molecular Weight: 1183.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O)C1CCCC1
Standard InChI: InChI=1S/C59H98N12O13/c1-31(2)27-42(63-37(11)73)53(78)62-35(9)51(76)65-43(28-32(3)4)54(79)64-41(19-14-15-25-60)52(77)67-45(30-38-21-23-40(74)24-22-38)55(80)66-44(29-33(5)6)56(81)70-49(39-17-12-13-18-39)58(83)69-48(36(10)72)59(84)71-26-16-20-46(71)57(82)68-47(34(7)8)50(61)75/h21-24,31-36,39,41-49,72,74H,12-20,25-30,60H2,1-11H3,(H2,61,75)(H,62,78)(H,63,73)(H,64,79)(H,65,76)(H,66,80)(H,67,77)(H,68,82)(H,69,83)(H,70,81)/t35-,36+,41-,42-,43-,44-,45-,46-,47-,48-,49-/m0/s1
Standard InChI Key: PCYVRFDTEIZRCS-ROMUQHLUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1183.50 | Molecular Weight (Monoisotopic): 1182.7376 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
Source(1):